By Kelly A. Briganti, Editorial Director, G2 Intelligence
U.S. Department of Health and Human Services' (HHS) annual Health Datapalooza was held May 31 to June 3, 2015, promoting new ways to use health care data to improve delivery of services. The conference attended by data experts, entrepreneurs, technology developers and representatives of health care systems and communities has grown from a 45-person group who'd gathered 25 data sets five years ago to "more than 2,000 attendees, and thanks to leadership from…
Read more...
By Stephanie Murg, Managing Director, G2 Intelligence
The University of Texas MD Anderson Cancer Center (Houston) is teaming with Exact Sciences Corp. (Madison, Wisc.) on tests that can detect lung cancer at early stages. The partnership, announced June 4, will focus on developing and commercializing a blood-based lung cancer screening test to determine the need for low-dose computed tomography (LDCT) as well as a…
Read more...
By Ron Shinkman, Editor, Laboratory Industry Report
Opko Health, Inc., the Miami-based molecular lab, has come to an agreement to acquire Bio-Reference Laboratory for $1.47 billion in a stock swap deal.
Opko will pay the equivalent of $52.58 per share for Bio-Reference, which is a more than 60 percent premium over its closing price on June 3, the day before the deal was announced. Bio-Reference shareholders will receive 2.75 shares of Opko stock for…
Read more...
By Kelly A. Briganti, Editorial Director, G2 Intelligence
While mainstream media focuses on the Caitlyn Jenner story, laboratory managers may think it has absolutely no relevance to their work. But does it? The U.S. Department of Labor's Occupational Safety & Health Administration released a guideline June 1, addressing workplace restrooms and access for transgender workers. "A Guide to Restroom Access for Transgender Workers" (Guide) addresses an employer's responsibility under OSHA standards to…
Read more...
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
Multidisciplinary tumor boards can improve the clinical relevance of information derived from genomic testing, according to presenters at an extended education session "Expediting the Learning Curve for Applied Cancer Genomics" at the 2015 annual meeting of the American Society of Clinical Oncology (Chicago; May 29-June 2). Multidisciplinary tumor boards can help overcome…
Read more...
|
